Analysis and Review: Celiac Disease Diagnostics Market by Product – (Serology Rapid Testing Kits {Transglutaminase Antibody Test Kits, Endomysial Antibody Test Kits, and Anti-Giladin Antibody Test Kits} and Genetic Rapid Testing Kits) Technique – (Immunochromatography {Lateral Flow}, and ELISA {enzyme-linked immunosorbent assay}) Sample – (Blood Serum, and Body Fluids) End User – (Hospitals, Diagnostic Laboratories, Specialty Clinics, and Home Care Setting) and By Region- Forecast for 2023 – 2033
Increasing Prevalence of Celiac Disease and Rising Adoption of Diagnostic Tools will Propel Global Celiac Disease Diagnostics Market
According to Future Market Insights (FMI) analysis in a recent market survey, the global celiac disease diagnostics market was valued at US$ 271.3 Million in 2022 and is expected to reach US$ 647.3 Million by 2033.
Market Outlook:
Data Points
Market Insights
Market Value 2022
US$ 271.3 Million
Market Value 2023
US$ 292.8 Million
Market Value 2033
US$ 647.3 Million
CAGR 2023 to 2033
8.3%
Share of Top 5 Countries
58.4%
Key Players
Thermo Fisher Scientific Inc., PRIMA Lab SA, Glutenostics, Inc., NanoRepro AG., Targeted Genomics, YORKTEST Laboratories, Biohit Oyj, Labsystems Diagnostics Oy, RxHome Test, Biomerica, AESKU.GROUP GmbH, LaCAR MDx Technologies, J. Mitra & Co. Pvt. Ltd., Imaware, Vitrosens Biotechnology, Bio-Rad Laboratories Inc. Eurofins Scientific.
In Celiac Disease, body's immune system reacts to gluten, a protein found in wheat, rye and barley. This reaction damages the lining of the small intestine and can lead to a range of symptoms, including abdominal pain, bloating, diarrhoea, and weight loss. If left untreated, celiac disease can lead to serious complications, such as malnutrition and an increased risk of certain types of cancer.
Gluten is a protein that is present in wheat, barley, and rye that causes an immunological response in people with celiac disease. In this condition, eating gluten causes the small intestine to launch an immune response, which results in symptoms like diarrhea, bloating, vomiting, or abdominal pain.
Celiac disease is becoming more common across the globe. The increasing cases of celiac disease are linked with decreased microbial diversity compared to our ancestors due to antibiotics, increased C-sections, or low food diversity.
As per Beyond Celiac, an NGO dedicated to raising awareness about celiac disease, an estimated 1 in 133 Americans has celiac disease. They mentioned that several environmental causes, including, more amount of gluten provide to infants, use of antibiotics during a child's first year of life, early childhood illnesses, and reduced exposure to microbes early in life leads to overactive immune responses later in life and cause celiac diseases. The diagnostics of celiac disease generally involve serology testing that looks for antibodies in blood and genetic testing for human leucocytes antigens.
Thus, the increasing cases of celiac disease will lead to increased demand for diagnostics during the forecast period and drive the market growth at a high pace.
Overall, the adoption of celiac diseases diagnostics in healthcare facilities, which will boost the market in the coming years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales Analysis of Celiac Disease Diagnostics Market from 2012 to 2022 Vs Market Outlook for 2023 to 2033
Sales of the celiac disease diagnostics market grew at a CAGR of 5.6% between 2012 to 2022. The Celiac disease diagnostics market contributes 6.4% revenue share to the global autoimmune diseases diagnostics market which is valued at around US$ 4.25 Billion in 2022.
The usage of home-test kits for the diagnosis of celiac disease is leading to a boost for the market. There are several manufacturers that provide kits that help the patients measure their response to gluten and indicate their likelihood of having the disease.
The sample needed for the home test kits generally includes blood or swab. The results during the home test could be mailed to a lab for analysis. The labs generally provide easy-to-understand results within 5 to 7 business days that could be shown to healthcare professionals.
A few examples of the home-test kits include the Targeted Genomics Gluten ID Test, imaware Celiac Disease Screening Test, LetsGetChecked Celiac Test, Genovate DNA Celiac Disease Test and empowerDX Celiac Risk Gene Test.
Several manufacturers are involved in increased product launches for at-home test products.
For instance, on May 5, 2022, empowerDX launched the easy At-Home Celiac Disease Genetic Risk Test. Thus, the increased home-test kit adoption is expected to increase the market growth in the forecast period.
Governments around the world are taking initiatives to increase awareness about celiac disease and improve access to diagnostics and treatment. For example, some countries have introduced screening programs for celiac disease in high-risk populations. Point-of-care testing (POCT) for celiac disease is becoming increasingly popular as it allows for rapid diagnosis and treatment. POCT is especially useful in remote or underserved areas where access to laboratory testing may be limited.
Considering this, FMI expects the global market to grow at a CAGR of 8.3% through the forecasted years.
What are the Key Opportunities in the Celiac Disease Diagnostics Market?
Technological advances related to sample collection and efforts of manufacturers to create easy-to-use kits are increasing the demand for the market.
Manufacturers are focusing on using non-invasive options such as cheek swabs, which are easier to use and do not cause pain. The result could also be obtained in a few days and thus the adoption is high.
The use of newer diagnostic tools, including deamidated gliadin peptide, serologic tests for antibodies against tissue transglutaminase (tTG), greatly facilitates diagnosis. Tests for DQ8 molecules and celiac-permissive HLA DQ2 are also useful in defined clinical situations. These diagnostic options are widely being adopted to improve the diagnostic approaches for celiac disease.
Thus, with the easy diagnosis of celiac disease, there are increased opportunities for new and emerging manufacturers in the market of celiac disease diagnostics. Further investment by key players could also create opportunities in the market of celiac disease diagnostics.
Find your sweet spots for generating winning opportunities in this market.
Which Factors Could Possibly Restrain the Growth of Celiac Disease Diagnostics Market?
The procedure of testing for celiac disease is quite simple and the at-home celiac disease testing rate is also high. Although the testing kits claim to have high precision, there could be chances of inconsistency in the result as a result of false results.
There are several factors that lead to such instances such as the type of test, type of sample, and other similar factors.
For instance, as per the Celiac Disease Foundation, the convenient way to test for celiac disease is with the Tissue Transglutaminase IgA antibody (tTG-IgA). A chance of a false positive test result exists, particularly in persons without celiac disease who have concomitant autoimmune diseases such as autoimmune liver disease, type 1 diabetes, Hashimoto's thyroiditis, psoriatic or rheumatoid arthritis, or heart failure. Thus, other antibody tests are also available to confirm potential false positives or false negatives, but a biopsy of the small intestine is the only way to definitively diagnose celiac disease due to the risk of misleading antibody test results.
These factors are expected to hamper revenue growth of the celiac disease diagnostics market over the forecast period.
Country-wise Insights
What Makes the USA the Dominating Country in the Global Market?
The USA market is expected to register a CAGR of 7.6% during the forecast period.
Celiac disease is a relatively common autoimmune disorder, but its prevalence can vary across different populations and regions. In the United States, celiac disease is considered to be underdiagnosed, with a significant number of cases remaining undiagnosed or misdiagnosed.
According to estimates from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 1 in 141 Americans have celiac disease. However, it's important to note that this figure represents diagnosed cases, and the actual prevalence may be higher.
Due to the high prevalence, more treatments, products will experience a high adoption rate among patients. The demand for celiac disease diagnostics will increase due to high prevalence, which will drive the expansion of the market.
Why is Germany considered to be a Lucrative Segment for Celiac Disease Diagnostics Market in Europe?
Germany dominated the European market for celiac disease diagnostics and accounted for around 25.6% of the market share in 2022.
Increasing technological advancements in celiac disease diagnostics in Germany is driving the overall Europe market. These advancements aim to improve the accuracy, efficiency, and convenience of diagnosing and managing the condition. Here are a few notable technological advancements in Germany for celiac disease diagnostics
Additionally, Genetic testing plays a role in identifying certain genetic markers associated with celiac disease. Germany, like other countries, has seen advancements in genetic testing technologies, making it easier and more accessible to analyze an individual's genetic profile to determine the presence of genes like HLA-DQ2 and HLA-DQ8, which are associated with an increased risk of developing celiac disease. Genetic testing can help in cases where there is diagnostic uncertainty or when other diagnostic methods are inconclusive, ultimately expanding the overall market.
What Makes China an Emerging Market for Celiac Disease Diagnostics?
China is projected to be the most attractive market in the celiac disease diagnostics, and is expected to grow over a significant CAGR of 9.9%.
The celiac disease diagnostics market in China is expected to grow significantly in the coming years due to several factors.
One of the main factors driving the growth of the celiac disease diagnostics in China is the increasing awareness of the condition among the general public and healthcare professionals. As more people become aware of the condition, they are more likely to seek diagnostics and treatment, which is leading to increased demand for diagnostics for celiac disease.
Another factor contributing to the growth of the China market is the increasing availability of advanced medical technologies and treatments. China has made significant investments in its healthcare infrastructure, and many new hospitals and clinics have been built in recent years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Why Product Is Largely Adopted Diagnostics Test for Celiac Disease?
The serology rapid testing kits segment held the major chunk of about 72.4% in global market by the end of 2022.
Serology rapid testing kits provide quick results, often within minutes, allowing for immediate diagnosis or screening. This speed is particularly beneficial in situations where prompt decision-making is necessary, such as in point-of-care settings or during emergency situations.
Serology rapid testing kits enable testing to be conducted at the point of care, eliminating the need for sending samples to a laboratory. This convenience improves accessibility, especially in remote or resource-limited areas, where access to laboratory facilities may be challenging.
Why ELISA (enzyme-linked immunosorbent assay) Is Dominating Technique for Celiac Disease Diagnostics?
The ELISA segment held the major chunk of about 56.7% in global market by the end of 2022.
The enzyme-linked immunosorbent assay (ELISA) technique has been widely used in celiac disease diagnostics for many years and continues to be an essential tool in this field. ELISA is a laboratory-based test that measures the presence and concentration of specific antibodies in a patient's blood sample.
ELISA has demonstrated high sensitivity and specificity in detecting celiac-specific antibodies. Sensitivity refers to the ability of the test to correctly identify individuals with celiac disease, while specificity refers to its ability to correctly identify individuals without the disease. ELISA tests designed for celiac disease diagnostics have been optimized to achieve reliable and accurate results. This is adding value to the market.
Which Sample Dominates the Global Market in 2022?
The blood serum segment accounted for revenue share of 74.1% in the global market at the end of 2022.
Blood serum plays a crucial role in celiac disease diagnostics. It is used to analyze various biomarkers and antibodies associated with the condition. Serologic tests measure specific antibodies present in the blood serum that indicate an immune response to gluten. These tests are the primary screening method for celiac disease. The most commonly measured antibodies include tissue transglutaminase antibodies (tTG), deamidated gliadin peptide antibodies (DGP), and endomysial antibodies (EMA).
Blood serum provides valuable information in celiac disease diagnostics, allowing healthcare professionals to assess antibody levels, detect IgA deficiency, monitor disease progression, and evaluate treatment response.
Which End User Dominates the Global Market in 2022?
The diagnostic laboratories segment accounted for revenue share of 44.0% in the global market at the end of 2022.
Diagnostic laboratories play a crucial role in celiac disease diagnostics. These specialized laboratories perform a range of tests and analyses to aid in the accurate diagnosis and monitoring of the condition. Diagnostic laboratories also contribute to research and development efforts in celiac disease diagnostics. They participate in studies and clinical trials to explore new diagnostic methods, evaluate the performance of novel biomarkers, and enhance the accuracy and efficiency of existing tests.
Competitive Landscape
Key players in the market are focused on increase their product portfolio to strengthen their position in the market, and also to expand their footprint in emerging markets. The key strategy adopted by manufacturers to gain competitive edge in the market are the partnerships and acquisition of other companies to expand their business.
For instance:
Thermo Fisher Scientific Inc. announced in December 2021 that it would purchase PPD Inc., a significant global provider of clinical research services to the biopharmaceutical and biotech industries.
In November 2017, The company Glutenostics announced the partnership with Major US Celiac Advocacy Groups
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the celiac disease diagnostics market space, which are available in the full report
Scope of the Celiac Disease Diagnostics Report
Attribute
Details
Forecast Period
2023 to 2033
Historical Data Available for
2012 to 2022
Market Analysis
USD Million for Value
Key Regions Covered
North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East, and Africa (MEA)
Key Countries Covered
US, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, Russia, BENELUX, Nordics, India, Thailand, Indonesia, Malaysia, Philippines, Vietnam, China, Japan, South Korea, Australia, New Zealand, Türkiye, Israel, South Africa, North Africa, and GCC Countries
Key Segments Covered in Celiac Disease Diagnostics Industry Research
By Product Type:
Serology Rapid Testing Kits
Transglutaminase Antibody Test Kits
Endomysial Antibody Test Kits
Anti-Giladin Antibody Test Kits
Genetic Rapid Testing Kits
By Technique:
Immunochromatography (Lateral Flow)
enzyme-linked immunosorbent assay (ELISA)
By Sample:
Blood Serum
Body Fluids
By End User:
Hospitals
Diagnostic Laboratories
Specialty Clinics
Home Care Setting
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Frequently Asked Questions
What Company Macarons are Best in the United States and Europe?
Chantal Guillon, Dana’s Bakery, and Dollayau are the top manufacturers in the United States and Europe.
How Big is the Global Celiac Disease Diagnostics Market?
The net worth of the market is almost US$ 292.8 million in 2023.
What is the Estimated Revenue from Celiac Disease Diagnostics by 2033?
The net revenue is likely to surpass US$ 647.3 million by 2033.
What is the Market Size for the Celiac Disease Diagnostics in China?
The demand in China is expected to surge at 9.9% CAGR through 2033.
Which is the Dominating Segment in the Global Celiac Disease Diagnostics Market?
Serology rapid testing kit segment share was nearly 72.4% in 2022.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value-Added Insights
4.1. Disease Epidemiology
4.2. Pipeline Assessment
4.3. Product Adoption/Usage Analysis
4.4. Regulatory Scenario
4.5. Reimbursement Guidelines
4.6. PESTLE Analysis
4.7. Porter’s Analysis
4.8. Value Chain Analysis
4.9. Industry Leaders | Key Promotional Strategies
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Autoimmune Diseases Diagnostics Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Growth in Healthcare Spending
5.2.2. Increase in Diagnosis of Celiac Disease
5.2.3. Growth in Geriatric Population
5.2.4. Product Launches
5.2.5. Increasing Research and Development
5.2.6. Collaborations With e-Commerce Partners
5.2.7. Regulatory Impositions
5.2.8. Strategic Mergers and Acquisitions Among Local Manufacturers
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Technique
6.1.3. By Sample
6.1.4. By Distribution Channel
6.1.5. By Region
6.2. 2022 Market Scenario
7. Global Market Demand (in Volume (Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Volume (Units) Analysis, 2012 to 2022
7.2. Current and Future Market Volume (Units) (Units) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Pricing Break-up
8.2.1. Manufacturer-Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value US$ Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033
9.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022
9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
9.3. Revenue Opportunity Scenario
10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Product, 2012 to 2022
10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast, by Product, 2023 to 2033
10.3.1. Serology Rapid Testing Kits
10.3.1.1. Transglutaminase Antibody Test Kits
10.3.1.2. Endomysial Antibody Test Kits
10.3.1.3. Anti-Giladin Antibody Test Kits
10.3.2. Genetic Rapid Testing Kits
10.4. Market Attractiveness Analysis, by Product
11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Technique
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis, By Technique, 2012 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Technique, 2023 to 2033
11.3.1. Immunochromatography (Lateral Flow)
11.3.2. ELISA (enzyme-linked immunosorbent assay)
11.4. Market Attractiveness Analysis, by Technique
12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Sample
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis, By Sample, 2012 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by Sample, 2023 to 2033
12.3.1. Blood Serum
12.3.2. Body Fluids
12.4. Market Attractiveness Analysis, by Sample
13. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) Analysis, By End User, 2012 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast, by End User, 2023 to 2033
13.3.1. Hospitals
13.3.2. Diagnostic Laboratories
13.3.3. Specialty Clinics
13.3.4. Home Care Setting
13.4. Market Attractiveness Analysis, by End User
14. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Region
14.1. Introduction
14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Region, 2012 to 2022
14.3. Current and Future Market Value (US$ Million) Volume (Units) Analysis and Forecast, By Region, 2023 to 2033
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. South Asia
14.3.5. East Asia
14.3.6. Oceania
14.3.7. Middle East and Africa (MEA)
14.4. Market Attractiveness Analysis, by Region
15. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2012 to 2022
15.3. Current and Future Market Value (US$ Million) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. USA
15.3.1.2. Canada
15.3.2. By Product
15.3.3. By Technique
15.3.4. By Sample
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Technique
15.4.4. By Sample
15.4.5. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country-Level Analysis & Forecast
15.8.1. USA Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast, by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Technique
15.8.1.2.3. By Sample
15.8.1.2.4. By End User
15.8.2. Canada Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast, by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Technique
15.8.2.2.3. By Sample
15.8.2.2.4. By End User
16. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2012 to 2022
16.3. Current and Future Market Value (US$ Million) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Mexico
16.3.1.2. Brazil
16.3.1.3. Argentina
16.3.1.4. Rest of Latin America
16.3.2. By Product
16.3.3. By Technique
16.3.4. By Sample
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Technique
16.4.4. By Sample
16.4.5. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country-Level Analysis & Forecast
16.8.1. Mexico Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast, by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Technique
16.8.1.2.3. By Sample
16.8.1.2.4. By End User
16.8.2. Brazil Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast, by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Technique
16.8.2.2.3. By Sample
16.8.2.2.4. By End User
16.8.3. Argentina Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast, by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Technique
16.8.3.2.3. By Sample
16.8.3.2.4. By End User
17. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2012 to 2022
17.3. Current and Future Market Value (US$ Million) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4. United Kingdom
17.3.1.5. Spain
17.3.1.6. BENELUX
17.3.1.7. Russia
17.3.1.8. Nordic Countries
17.3.1.9. Rest of Europe
17.3.2. By Product
17.3.3. By Technique
17.3.4. By Sample
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Technique
17.4.4. By Sample
17.4.5. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country-Level Analysis & Forecast
17.8.1. Germany Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Technique
17.8.1.2.3. By Sample
17.8.1.2.4. By End User
17.8.2. Italy Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Technique
17.8.2.2.3. By Sample
17.8.2.2.4. By End User
17.8.3. France Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast, by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Technique
17.8.3.2.3. By Sample
17.8.3.2.4. By End User
17.8.4. United Kingdom Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast, by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Technique
17.8.4.2.3. By Sample
17.8.4.2.4. By End User
17.8.5. Spain Market Analysis
17.8.5.1. Introduction
17.8.5.2. Market Analysis and Forecast, by Market Taxonomy
17.8.5.2.1. By Product
17.8.5.2.2. By Technique
17.8.5.2.3. By Sample
17.8.5.2.4. By End User
17.8.6. BENELUX Market Analysis
17.8.6.1. Introduction
17.8.6.2. Market Analysis and Forecast, by Market Taxonomy
17.8.6.2.1. By Product
17.8.6.2.2. By Technique
17.8.6.2.3. By Sample
17.8.6.2.4. By End User
17.8.7. Russia Market Analysis
17.8.7.1. Introduction
17.8.7.2. Market Analysis and Forecast, by Market Taxonomy
17.8.7.2.1. By Product
17.8.7.2.2. By Technique
17.8.7.2.3. By Sample
17.8.7.2.4. By End User
17.8.8. Nordic Countries Market Analysis
17.8.8.1. Introduction
17.8.8.2. Market Analysis and Forecast, by Market Taxonomy
17.8.8.2.1. By Product
17.8.8.2.2. By Technique
17.8.8.2.3. By Sample
17.8.8.2.4. By End User
18. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market End User (US$ Million) Analysis, by Market Taxonomy, 2012 to 2022
18.3. Current and Future Market Value (US$ Million) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.2. By Product
18.3.3. By Technique
18.3.4. By Sample
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Technique
18.4.4. By Sample
18.4.5. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country-Level Analysis & Forecast
18.8.1. China Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Technique
18.8.1.2.3. By Sample
18.8.1.2.4. By End User
18.8.2. Japan Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Technique
18.8.2.2.3. By Sample
18.8.2.2.4. By End User
18.8.3. South Korea Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast, by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Technique
18.8.3.2.3. By Sample
18.8.3.2.4. By End User
19. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2012 to 2022
19.3. Current and Future Market Value (US$ Million) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. India
19.3.1.2. Indonesia
19.3.1.3. Malaysia
19.3.1.4. Thailand
19.3.1.5. Philippines
19.3.1.6. Vietnam
19.3.1.7. Rest of South Asia
19.3.2. By Product
19.3.3. By Technique
19.3.4. By Sample
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Technique
19.4.4. By Sample
19.4.5. By End User
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country-Level Analysis & Forecast
19.8.1. India Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast, by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Technique
19.8.1.2.3. By Sample
19.8.1.2.4. By End User
19.8.2. Indonesia Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast, by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Technique
19.8.2.2.3. By Sample
19.8.2.2.4. By End User
19.8.3. Malaysia Market Analysis
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast, by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By Technique
19.8.3.2.3. By Sample
19.8.3.2.4. By End User
19.8.4. Thailand Market Analysis
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast, by Market Taxonomy
19.8.4.2.1. By Product
19.8.4.2.2. By Technique
19.8.4.2.3. By Sample
19.8.4.2.4. By End User
19.8.5. Philippines Market Analysis
19.8.5.1. Introduction
19.8.5.2. Market Analysis and Forecast, by Market Taxonomy
19.8.5.2.1. By Product
19.8.5.2.2. By Technique
19.8.5.2.3. By Sample
19.8.5.2.4. By End User
19.8.6. Vietnam Market Analysis
19.8.6.1. Introduction
19.8.6.2. Market Analysis and Forecast, by Market Taxonomy
19.8.6.2.1. By Product
19.8.6.2.2. By Technique
19.8.6.2.3. By Sample
19.8.6.2.4. By End User
20. Oceania Market 2012 to 2022 and Forecast 2022 to 2033
20.1. Introduction
20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2012 to 2022
20.3. Current and Future Market Value (US$ Million) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
20.3.1. By Country
20.3.1.1. Australia
20.3.1.2. New Zealand
20.3.2. By Product
20.3.3. By Technique
20.3.4. By Sample
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Technique
20.4.4. By Sample
20.4.5. By End User
20.5. Market Trends
20.6. Key Market Participants – Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
20.8. Country-Level Analysis & Forecast
20.8.1. Australia Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast, by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Technique
20.8.1.2.3. By Sample
20.8.1.2.4. By End User
20.8.2. New Zealand Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast, by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Technique
20.8.2.2.3. By Sample
20.8.2.2.4. By End User
21. Middle East and Africa (MEA) Market Analysis 2012 to 2022 and Forecast 2023 to 2033
21.1. Introduction
21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, by Market Taxonomy, 2012 to 2022
21.3. Current and Future Market Value (US$ Million) Volume (Units) Analysis and Forecast, by Market Taxonomy, 2023 to 2033
21.3.1. By Country
21.3.1.1. GCC Countries
21.3.1.2. Türkiye
21.3.1.3. Israel
21.3.1.4. South Africa
21.3.1.5. North Africa
21.3.1.6. Rest of Middle East and Africa
21.3.2. By Product
21.3.3. By Technique
21.3.4. By Sample
21.3.5. By End User
21.4. Market Attractiveness Analysis
21.4.1. By Country
21.4.2. By Product
21.4.3. By Technique
21.4.4. By Sample
21.4.5. By End User
21.5. Market Trends
21.6. Key Market Participants - Intensity Mapping
21.7. Drivers and Restraints - Impact Analysis
21.8. Country-Level Analysis & Forecast
21.8.1. GCC Countries Market Analysis
21.8.1.1. Introduction
21.8.1.2. Market Analysis and Forecast, by Market Taxonomy
21.8.1.2.1. By Product
21.8.1.2.2. By Technique
21.8.1.2.3. By Sample
21.8.1.2.4. By End User
21.8.2. Türkiye Market Analysis
21.8.2.1. Introduction
21.8.2.2. Market Analysis and Forecast, by Market Taxonomy
21.8.2.2.1. By Product
21.8.2.2.2. By Technique
21.8.2.2.3. By Sample
21.8.2.2.4. By End User
21.8.3. Israel Africa Market Analysis
21.8.3.1. Introduction
21.8.3.2. Market Analysis and Forecast, by Market Taxonomy
21.8.3.2.1. By Product
21.8.3.2.2. By Technique
21.8.3.2.3. By Sample
21.8.3.2.4. By End User
21.8.4. South Africa Market Analysis
21.8.4.1. Introduction
21.8.4.2. Market Analysis and Forecast, by Market Taxonomy
21.8.4.2.1. By Product
21.8.4.2.2. By Technique
21.8.4.2.3. By Sample
21.8.4.2.4. By End User
21.8.5. North Africa Market Analysis
21.8.5.1. Introduction
21.8.5.2. Market Analysis and Forecast, by Market Taxonomy
21.8.5.2.1. By Product
21.8.5.2.2. By Technique
21.8.5.2.3. By Sample
21.8.5.2.4. By End User
22. Market Structure Analysis
22.1. Market Analysis, by Tier of Companies
22.2. Market Share Analysis of Top Players
22.3. Market Presence Analysis
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Key Development Analysis
23.4. Competition Deep Dive
23.4.1. Thermo Fisher Scientific Inc.
23.4.1.1. Overview
23.4.1.2. Product Portfolio
23.4.1.3. Sales Footprint
23.4.1.4. Key Financials
23.4.1.5. SWOT Analysis
23.4.1.6. Key Developments
23.4.1.7. Strategy Overview
23.4.1.7.1. Marketing Strategy
23.4.1.7.2. Product Strategy
23.4.1.7.3. Channel Strategy
23.4.2. PRIMA Lab SA
23.4.2.1. Overview
23.4.2.2. Product Portfolio
23.4.2.3. Sales Footprint
23.4.2.4. Key Financials
23.4.2.5. SWOT Analysis
23.4.2.6. Key Developments
23.4.2.7. Strategy Overview
23.4.2.7.1. Marketing Strategy
23.4.2.7.2. Product Strategy
23.4.2.7.3. Channel Strategy
23.4.3. Glutenostics, Inc.
23.4.3.1. Overview
23.4.3.2. Product Portfolio
23.4.3.3. Sales Footprint
23.4.3.4. Key Financials
23.4.3.5. SWOT Analysis
23.4.3.6. Key Developments
23.4.3.7. Strategy Overview
23.4.3.7.1. Marketing Strategy
23.4.3.7.2. Product Strategy
23.4.3.7.3. Channel Strategy
23.4.4. NanoRepro AG.
23.4.4.1. Overview
23.4.4.2. Product Portfolio
23.4.4.3. Sales Footprint
23.4.4.4. Key Financials
23.4.4.5. SWOT Analysis
23.4.4.6. Key Developments
23.4.4.7. Strategy Overview
23.4.4.7.1. Marketing Strategy
23.4.4.7.2. Product Strategy
23.4.4.7.3. Channel Strategy
23.4.5. Targeted Genomics
23.4.5.1. Overview
23.4.5.2. Product Portfolio
23.4.5.3. Sales Footprint
23.4.5.4. Key Financials
23.4.5.5. SWOT Analysis
23.4.5.6. Key Developments
23.4.5.7. Strategy Overview
23.4.5.7.1. Marketing Strategy
23.4.5.7.2. Product Strategy
23.4.5.7.3. Channel Strategy
23.4.6. YORKTEST Laboratories
23.4.6.1. Overview
23.4.6.2. Product Portfolio
23.4.6.3. Sales Footprint
23.4.6.4. Key Financials
23.4.6.5. SWOT Analysis
23.4.6.6. Key Developments
23.4.6.7. Strategy Overview
23.4.6.7.1. Marketing Strategy
23.4.6.7.2. Product Strategy
23.4.6.7.3. Channel Strategy
23.4.7. Biohit Oyj
23.4.7.1. Overview
23.4.7.2. Product Portfolio
23.4.7.3. Sales Footprint
23.4.7.4. Key Financials
23.4.7.5. SWOT Analysis
23.4.7.6. Key Developments
23.4.7.7. Strategy Overview
23.4.7.7.1. Marketing Strategy
23.4.7.7.2. Product Strategy
23.4.7.7.3. Channel Strategy
23.4.8. Labsystems Diagnostics Oy
23.4.8.1. Overview
23.4.8.2. Product Portfolio
23.4.8.3. Sales Footprint
23.4.8.4. Key Financials
23.4.8.5. SWOT Analysis
23.4.8.6. Key Developments
23.4.8.7. Strategy Overview
23.4.8.7.1. Marketing Strategy
23.4.8.7.2. Product Strategy
23.4.8.7.3. Channel Strategy
23.4.9. RxHome Test
23.4.9.1. Overview
23.4.9.2. Product Portfolio
23.4.9.3. Sales Footprint
23.4.9.4. Key Financials
23.4.9.5. SWOT Analysis
23.4.9.6. Key Developments
23.4.9.7. Strategy Overview
23.4.9.7.1. Marketing Strategy
23.4.9.7.2. Product Strategy
23.4.9.7.3. Channel Strategy
23.4.10. Biomerica
23.4.10.1. Overview
23.4.10.2. Product Portfolio
23.4.10.3. Sales Footprint
23.4.10.4. Key Financials
23.4.10.5. SWOT Analysis
23.4.10.6. Key Developments
23.4.10.7. Strategy Overview
23.4.10.7.1. Marketing Strategy
23.4.10.7.2. Product Strategy
23.4.10.7.3. Channel Strategy
23.4.11. AESKU.GROUP GmbH
23.4.11.1. Overview
23.4.11.2. Product Portfolio
23.4.11.3. Sales Footprint
23.4.11.4. Key Financials
23.4.11.5. SWOT Analysis
23.4.11.6. Key Developments
23.4.11.7. Strategy Overview
23.4.11.7.1. Marketing Strategy
23.4.11.7.2. Product Strategy
23.4.11.7.3. Channel Strategy
23.4.12. LaCAR MDx Technologies
23.4.12.1. Overview
23.4.12.2. Product Portfolio
23.4.12.3. Sales Footprint
23.4.12.4. Key Financials
23.4.12.5. SWOT Analysis
23.4.12.6. Key Developments
23.4.12.7. Strategy Overview
23.4.12.7.1. Marketing Strategy
23.4.12.7.2. Product Strategy
23.4.12.7.3. Channel Strategy
23.4.13. J. Mitra & Co. Pvt. Ltd.
23.4.13.1. Overview
23.4.13.2. Product Portfolio
23.4.13.3. Sales Footprint
23.4.13.4. Key Financials
23.4.13.5. SWOT Analysis
23.4.13.6. Key Developments
23.4.13.7. Strategy Overview
23.4.13.7.1. Marketing Strategy
23.4.13.7.2. Product Strategy
23.4.13.7.3. Channel Strategy
23.4.14. Imaware
23.4.14.1. Overview
23.4.14.2. Product Portfolio
23.4.14.3. Sales Footprint
23.4.14.4. Key Financials
23.4.14.5. SWOT Analysis
23.4.14.6. Key Developments
23.4.14.7. Strategy Overview
23.4.14.7.1. Marketing Strategy
23.4.14.7.2. Product Strategy
23.4.14.7.3. Channel Strategy
23.4.15. Vitrosens Biotechnology
23.4.15.1. Overview
23.4.15.2. Product Portfolio
23.4.15.3. Sales Footprint
23.4.15.4. Key Financials
23.4.15.5. SWOT Analysis
23.4.15.6. Key Developments
23.4.15.7. Strategy Overview
23.4.15.7.1. Marketing Strategy
23.4.15.7.2. Product Strategy
23.4.15.7.3. Channel Strategy
23.4.16. Bio-Rad Laboratories Inc.
23.4.16.1. Overview
23.4.16.2. Product Portfolio
23.4.16.3. Sales Footprint
23.4.16.4. Key Financials
23.4.16.5. SWOT Analysis
23.4.16.6. Key Developments
23.4.16.7. Strategy Overview
23.4.16.7.1. Marketing Strategy
23.4.16.7.2. Product Strategy
23.4.16.7.3. Channel Strategy
23.4.17. Eurofins Scientific
23.4.17.1. Overview
23.4.17.2. Product Portfolio
23.4.17.3. Sales Footprint
23.4.17.4. Key Financials
23.4.17.5. SWOT Analysis
23.4.17.6. Key Developments
23.4.17.7. Strategy Overview
23.4.17.7.1. Marketing Strategy
23.4.17.7.2. Product Strategy
23.4.17.7.3. Channel Strategy
24. Assumptions and Acronyms Used25. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 02: Global Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 03: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Technique
Table 04: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 05: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 06: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Region
Table 07: North America Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 08: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 09: North America Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 10: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Technique
Table 11: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 12: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 13: Latin America Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 14: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 15: Latin America Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 16: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Technique
Table 17: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 18: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 19: Europe Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 20: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 21: Europe Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 22: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Technique
Table 23: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 24: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 25: South Asia Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 26: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 27: South Asia Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 28: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Technique
Table 29: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 30: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 31: East Asia Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 32: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 33: East Asia Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 34: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Technique
Table 35: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 36: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 37: Oceania Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 38: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 39: Oceania Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 40: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Technique
Table 41: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 42: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Table 43: Middle East & Africa Market Value (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, by Country
Table 44: Middle East & Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product
Table 45: Middle East & Africa Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product
Table 46: Middle East & Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Technique
Table 47: Middle East & Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample
Table 48: Middle East & Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Market Volume (Units), 2012 to 2022
Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis,
Figure 03: Pricing Analysis per unit (US$), in 2022
Figure 04: Pricing Forecast per unit (US$), in 2033
Figure 05: Global Market Value (US$ Million) Analysis, 2012 to 2022
Figure 06: Global Market Forecast & Y-o-Y Growth, 2022 to 2033
Figure 07: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022 to 2033
Figure 08: Global Market Value Share (%) Analysis 2022 and 2033, by Product
Figure 09: Global Market Y-o-Y Growth (%) Analysis 2023 to 2033, by Product
Figure 10: Global Market Attractiveness Analysis 2022 to 2033, by Product
Figure 11: Global Market Value Share (%) Analysis 2022 and 2033, by Technique
Figure 12: Global Market Y-o-Y Growth (%) Analysis 2023 to 2033, by Technique
Figure 13: Global Market Attractiveness Analysis 2022 to 2033, by Technique
Figure 14: Global Market Value Share (%) Analysis 2022 and 2033, by Sample
Figure 15: Global Market Y-o-Y Growth (%) Analysis 2023 to 2033, by Sample
Figure 16: Global Market Attractiveness Analysis 2022 to 2033, by Sample
Figure 17: Global Market Value Share (%) Analysis 2022 and 2033, by End User
Figure 18: Global Market Y-o-Y Growth (%) Analysis 2023 to 2033, by End User
Figure 19: Global Market Attractiveness Analysis 2022 to 2033, by End User
Figure 20: Global Market Value Share (%) Analysis 2022 and 2033, by Region
Figure 21: Global Market Y-o-Y Growth (%) Analysis 2023 to 2033, by Region
Figure 22: Global Market Attractiveness Analysis 2022 to 2033, by Region
Figure 23: North America Market Value (US$ Million) Analysis, 2012 to 2022
Figure 24: North America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 25: North America Market Value Share, by Product (2023 E)
Figure 26: North America Market Value Share, by Technique (2023 E)
Figure 27: North America Market Value Share, by Sample (2023 E)
Figure 28: North America Market Value Share, by End User (2023 E)
Figure 29: North America Market Value Share, by Country (2023 E)
Figure 30: North America Market Attractiveness Analysis by Product, 2022 to 2033
Figure 31: North America Market Attractiveness Analysis by Technique, 2022 to 2033
Figure 32: North America Market Attractiveness Analysis by Sample, 2022 to 2033
Figure 33: North America Market Attractiveness Analysis by End User, 2022 to 2033
Figure 34: North America Market Attractiveness Analysis by Country, 2022 to 2033
Figure 35: USA Market Value Proportion Analysis, 2022
Figure 36: Global Vs. USA Growth Comparison
Figure 37: USA Market Share Analysis (%) by Product, 2022 & 2033
Figure 38: USA Market Share Analysis (%) by Technique, 2022 & 2033
Figure 39: USA Market Share Analysis (%) by Sample, 2022 & 2033
Figure 40: USA Market Share Analysis (%) by End User, 2022 & 2033
Figure 41: Canada Market Value Proportion Analysis, 2022
Figure 42: Global Vs. Canada. Growth Comparison
Figure 43: Canada Market Share Analysis (%) by Product, 2022 & 2033
Figure 44: Canada Market Share Analysis (%) by Technique, 2022 & 2033
Figure 45: Canada Market Share Analysis (%) by Sample, 2022 & 2033
Figure 46: Canada Market Share Analysis (%) by End User, 2022 & 2033
Figure 47: Latin America Market Value (US$ Million) Analysis, 2012 to 2022
Figure 48: Latin America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 49: Latin America Market Value Share, by Product (2023 E)
Figure 50: Latin America Market Value Share, by Technique (2023 E)
Figure 51: Latin America Market Value Share, by Sample (2023 E)
Figure 52: Latin America Market Value Share, by End User (2023 E)
Figure 53: Latin America Market Value Share, by Country (2023 E)
Figure 54: Latin America Market Attractiveness Analysis by Product, 2022 to 2033
Figure 55: Latin America Market Attractiveness Analysis by Technique, 2022 to 2033
Figure 56: Latin America Market Attractiveness Analysis by Sample, 2022 to 2033
Figure 57: Latin America Market Attractiveness Analysis by End User, 2022 to 2033
Figure 58: Latin America Market Attractiveness Analysis by Country, 2022 to 2033
Figure 59: Mexico Market Value Proportion Analysis, 2022
Figure 60: Global Vs Mexico Growth Comparison
Figure 61: Mexico Market Share Analysis (%) by Product, 2022 & 2033
Figure 62: Mexico Market Share Analysis (%) by Technique, 2022 & 2033
Figure 63: Mexico Market Share Analysis (%) by Sample, 2022 & 2033
Figure 64: Mexico Market Share Analysis (%) by End User, 2022 & 2033
Figure 65: Brazil Market Value Proportion Analysis, 2022
Figure 66: Global Vs. Brazil. Growth Comparison
Figure 67: Brazil Market Share Analysis (%) by Product, 2022 & 2033
Figure 68: Brazil Market Share Analysis (%) by Technique, 2022 & 2033
Figure 69: Brazil Market Share Analysis (%) by Sample, 2022 & 2033
Figure 70: Brazil Market Share Analysis (%) by End User, 2022 & 2033
Figure 71: Argentina Market Value Proportion Analysis, 2022
Figure 72: Global Vs Argentina Growth Comparison
Figure 73: Argentina Market Share Analysis (%) by Product, 2022 & 2033
Figure 74: Argentina Market Share Analysis (%) by Technique, 2022 & 2033
Figure 75: Argentina Market Share Analysis (%) by Sample, 2022 & 2033
Figure 76: Argentina Market Share Analysis (%) by End User, 2022 & 2033
Figure 77: Europe Market Value (US$ Million) Analysis, 2012 to 2022
Figure 78: Europe Market Value (US$ Million) Forecast, 2023 to 2033
Figure 79: Europe Market Value Share, by Product (2023 E)
Figure 80: Europe Market Value Share, by Technique (2023 E)
Figure 81: Europe Market Value Share, by Sample (2023 E)
Figure 82: Europe Market Value Share, by End User (2023 E)
Figure 83: Europe Market Value Share, by Country (2023 E)
Figure 84: Europe Market Attractiveness Analysis by Product, 2022 to 2033
Figure 85: Europe Market Attractiveness Analysis by Technique, 2022 to 2033
Figure 86: Europe Market Attractiveness Analysis by Sample, 2022 to 2033
Figure 87: Europe Market Attractiveness Analysis by End User, 2022 to 2033
Figure 88: Europe Market Attractiveness Analysis by Country, 2022 to 2033
Figure 89: UK Market Value Proportion Analysis, 2022
Figure 90: Global Vs. UK Growth Comparison
Figure 91: UK Market Share Analysis (%) by Product, 2022 & 2033
Figure 92: UK Market Share Analysis (%) by Technique, 2022 & 2033
Figure 93: UK Market Share Analysis (%) by Sample, 2022 & 2033
Figure 94: UK Market Share Analysis (%) by End User, 2022 & 2033
Figure 95: Germany Market Value Proportion Analysis, 2022
Figure 96: Global Vs. Germany Growth Comparison
Figure 97: Germany Market Share Analysis (%) by Product, 2022 & 2033
Figure 98: Germany Market Share Analysis (%) by Technique, 2022 & 2033
Figure 99: Germany Market Share Analysis (%) by Sample, 2022 & 2033
Figure 100: Germany Market Share Analysis (%) by End User, 2022 & 2033
Figure 101: Italy Market Value Proportion Analysis, 2022
Figure 102: Global Vs. Italy Growth Comparison
Figure 103: Italy Market Share Analysis (%) by Product, 2022 & 2033
Figure 104: Italy Market Share Analysis (%) by Technique, 2022 & 2033
Figure 105: Italy Market Share Analysis (%) by Sample, 2022 & 2033
Figure 106: Italy Market Share Analysis (%) by End User, 2022 & 2033
Figure 107: France Market Value Proportion Analysis, 2022
Figure 108: Global Vs France Growth Comparison
Figure 109: France Market Share Analysis (%) by Product, 2022 & 2033
Figure 110: France Market Share Analysis (%) by Technique, 2022 & 2033
Figure 111: France Market Share Analysis (%) by Sample, 2022 & 2033
Figure 112: France Market Share Analysis (%) by End User, 2022 & 2033
Figure 113: Spain Market Value Proportion Analysis, 2022
Figure 114: Global Vs Spain Growth Comparison
Figure 115: Spain Market Share Analysis (%) by Product, 2022 & 2033
Figure 116: Spain Market Share Analysis (%) by Technique, 2022 & 2033
Figure 117: Spain Market Share Analysis (%) by Sample, 2022 & 2033
Figure 118: Spain Market Share Analysis (%) by End User, 2022 & 2033
Figure 119: Russia Market Value Proportion Analysis, 2022
Figure 120: Global Vs Russia Growth Comparison
Figure 121: Russia Market Share Analysis (%) by Product, 2022 & 2033
Figure 122: Russia Market Share Analysis (%) by Technique, 2022 & 2033
Figure 123: Russia Market Share Analysis (%) by Sample, 2022 & 2033
Figure 124: Russia Market Share Analysis (%) by End User, 2022 & 2033
Figure 125: BENELUX Market Value Proportion Analysis, 2022
Figure 126: Global Vs BENELUX Growth Comparison
Figure 127: BENELUX Market Share Analysis (%) by Product, 2022 & 2033
Figure 128: BENELUX Market Share Analysis (%) by Technique, 2022 & 2033
Figure 129: BENELUX Market Share Analysis (%) by Sample, 2022 & 2033
Figure 130: BENELUX Market Share Analysis (%) by End User, 2022 & 2033
Figure 131: Nordics Market Value Proportion Analysis, 2022
Figure 132: Global Vs Nordics Growth Comparison
Figure 133: Nordics Market Share Analysis (%) by Product, 2022 & 2033
Figure 134: Nordics Market Share Analysis (%) by Technique, 2022 & 2033
Figure 135: Nordics Market Share Analysis (%) by Sample, 2022 & 2033
Figure 136: Nordics Market Share Analysis (%) by End User, 2022 & 2033
Figure 137: East Asia Market Value (US$ Million) Analysis, 2012 to 2022
Figure 138: East Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 139: East Asia Market Value Share, by Product (2023 E)
Figure 140: East Asia Market Value Share, by Technique (2023 E)
Figure 141: East Asia Market Value Share, by Sample (2023 E)
Figure 142: East Asia Market Value Share, by End User (2023 E)
Figure 143: East Asia Market Value Share, by Country (2023 E)
Figure 144: East Asia Market Attractiveness Analysis by Product, 2022 to 2033
Figure 145: East Asia Market Attractiveness Analysis by Technique, 2022 to 2033
Figure 146: East Asia Market Attractiveness Analysis by Sample, 2022 to 2033
Figure 147: East Asia Market Attractiveness Analysis by End User, 2022 to 2033
Figure 148: East Asia Market Attractiveness Analysis by Country, 2022 to 2033
Figure 149: China Market Value Proportion Analysis, 2022
Figure 150: Global Vs. China Growth Comparison
Figure 151: China Market Share Analysis (%) by Product, 2022 & 2033
Figure 152: China Market Share Analysis (%) by Technique, 2022 & 2033
Figure 153: China Market Share Analysis (%) by Sample, 2022 & 2033
Figure 154: China Market Share Analysis (%) by End User, 2022 & 2033
Figure 155: Japan Market Value Proportion Analysis, 2022
Figure 156: Global Vs. Japan Growth Comparison
Figure 157: Japan Market Share Analysis (%) by Product, 2022 & 2033
Figure 158: Japan Market Share Analysis (%) by Technique, 2022 & 2033
Figure 159: Japan Market Share Analysis (%) by Sample, 2022 & 2033
Figure 160: Japan Market Share Analysis (%) by End User, 2022 & 2033
Figure 161: South Korea Market Value Proportion Analysis, 2022
Figure 162: Global Vs South Korea Growth Comparison
Figure 163: South Korea Market Share Analysis (%) by Product, 2022 & 2033
Figure 164: South Korea Market Share Analysis (%) by Technique, 2022 & 2033
Figure 165: South Korea Market Share Analysis (%) by Sample, 2022 & 2033
Figure 166: South Korea Market Share Analysis (%) by End User, 2022 & 2033
Figure 167: South Asia Market Value (US$ Million) Analysis, 2012 to 2022
Figure 168: South Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 169: South Asia Market Value Share, by Product (2023 E)
Figure 170: South Asia Market Value Share, by Technique (2023 E)
Figure 171: South Asia Market Value Share, by Sample (2023 E)
Figure 172: South Asia Market Value Share, by End User (2023 E)
Figure 173: South Asia Market Value Share, by Country (2023 E)
Figure 174: South Asia Market Attractiveness Analysis by Product, 2022 to 2033
Figure 175: South Asia Market Attractiveness Analysis by Technique, 2022 to 2033
Figure 176: South Asia Market Attractiveness Analysis by Sample, 2022 to 2033
Figure 177: South Asia Market Attractiveness Analysis by End User, 2022 to 2033
Figure 178: South Asia Market Attractiveness Analysis by Country, 2022 to 2033
Figure 179: India Market Value Proportion Analysis, 2022
Figure 180: Global Vs. India Growth Comparison
Figure 181: India Market Share Analysis (%) by Product, 2022 & 2033
Figure 182: India Market Share Analysis (%) by Technique, 2022 & 2033
Figure 183: India Market Share Analysis (%) by Sample, 2022 & 2033
Figure 184: India Market Share Analysis (%) by End User, 2022 & 2033
Figure 185: Indonesia Market Value Proportion Analysis, 2022
Figure 186: Global Vs. Indonesia Growth Comparison
Figure 187: Indonesia Market Share Analysis (%) by Product, 2022 & 2033
Figure 188: Indonesia Market Share Analysis (%) by Technique, 2022 & 2033
Figure 189: Indonesia Market Share Analysis (%) by Sample, 2022 & 2033
Figure 190: Indonesia Market Share Analysis (%) by End User, 2022 & 2033
Figure 191: Malaysia Market Value Proportion Analysis, 2022
Figure 192: Global Vs. Malaysia Growth Comparison
Figure 193: Malaysia Market Share Analysis (%) by Product, 2022 & 2033
Figure 194: Malaysia Market Share Analysis (%) by Technique, 2022 & 2033
Figure 195: Malaysia Market Share Analysis (%) by Sample, 2022 & 2033
Figure 196: Malaysia Market Share Analysis (%) by End User, 2022 & 2033
Figure 197: Thailand Market Value Proportion Analysis, 2022
Figure 198: Global Vs. Thailand Growth Comparison
Figure 199: Thailand Market Share Analysis (%) by Product, 2022 & 2033
Figure 200: Thailand Market Share Analysis (%) by Technique, 2022 & 2033
Figure 201: Thailand Market Share Analysis (%) by Sample, 2022 & 2033
Figure 202: Thailand Market Share Analysis (%) by End User, 2022 & 2033
Figure 203: Vietnam Market Value Proportion Analysis, 2022
Figure 204: Global Vs. Vietnam Growth Comparison
Figure 205: Vietnam Market Share Analysis (%) by Product, 2022 & 2033
Figure 206: Vietnam Market Share Analysis (%) by Technique, 2022 & 2033
Figure 207: Vietnam Market Share Analysis (%) by Sample, 2022 & 2033
Figure 208: Vietnam Market Share Analysis (%) by End User, 2022 & 2033
Figure 209: Philippines Market Value Proportion Analysis, 2022
Figure 210: Global Vs. Philippines Growth Comparison
Figure 211: Philippines Market Share Analysis (%) by Product, 2022 & 2033
Figure 212: Philippines Market Share Analysis (%) by Technique, 2022 & 2033
Figure 213: Philippines Market Share Analysis (%) by Sample, 2022 & 2033
Figure 214: Philippines Market Share Analysis (%) by End User, 2022 & 2033
Figure 215: Oceania Market Value (US$ Million) Analysis, 2012 to 2022
Figure 216: Oceania Market Value (US$ Million) Forecast, 2023 to 2033
Figure 217: Oceania Market Value Share, by Product (2023 E)
Figure 218: Oceania Market Value Share, by Technique (2023 E)
Figure 219: Oceania Market Value Share, by Sample (2023 E)
Figure 220: Oceania Market Value Share, by End User (2023 E)
Figure 221: Oceania Market Value Share, by Country (2023 E)
Figure 222: Oceania Market Attractiveness Analysis by Product, 2022 to 2033
Figure 223: Oceania Market Attractiveness Analysis by Technique, 2022 to 2033
Figure 224: Oceania Market Attractiveness Analysis by Sample, 2022 to 2033
Figure 225: Oceania Market Attractiveness Analysis by End User, 2022 to 2033
Figure 226: Oceania Market Attractiveness Analysis by Country, 2022 to 2033
Figure 227: Australia Market Value Proportion Analysis, 2022
Figure 228: Global Vs. Australia Growth Comparison
Figure 229: Australia Market Share Analysis (%) by Product, 2022 & 2033
Figure 230: Australia Market Share Analysis (%) by Technique, 2022 & 2033
Figure 231: Australia Market Share Analysis (%) by Sample, 2022 & 2033
Figure 232: Australia Market Share Analysis (%) by End User, 2022 & 2033
Figure 233: New Zealand Market Value Proportion Analysis, 2022
Figure 234: Global Vs New Zealand Growth Comparison
Figure 235: New Zealand Market Share Analysis (%) by Product, 2022 & 2033
Figure 236: New Zealand Market Share Analysis (%) by Technique, 2022 & 2033
Figure 237: New Zealand Market Share Analysis (%) by Sample, 2022 & 2033
Figure 238: New Zealand Market Share Analysis (%) by End User, 2022 & 2033
Figure 239: Middle East & Africa Market Value (US$ Million) Analysis, 2012 to 2022
Figure 240: Middle East & Africa Market Value (US$ Million) Forecast, 2023 to 2033
Figure 241: Middle East & Africa Market Value Share, by Product (2023 E)
Figure 242: Middle East & Africa Market Value Share, by Technique (2023 E)
Figure 243: Middle East & Africa Market Value Share, by Sample (2023 E)
Figure 244: Middle East & Africa Market Value Share, by End User (2023 E)
Figure 245: Middle East & Africa Market Value Share, by Country (2023 E)
Figure 246: Middle East & Africa Market Attractiveness Analysis by Product, 2022 to 2033
Figure 247: Middle East & Africa Market Attractiveness Analysis by Technique, 2022 to 2033
Figure 248: Middle East & Africa Market Attractiveness Analysis by Sample, 2022 to 2033
Figure 249: Middle East & Africa Market Attractiveness Analysis by End User, 2022 to 2033
Figure 250: Middle East & Africa Market Attractiveness Analysis by Country, 2022 to 2033
Figure 251: GCC Countries Market Value Proportion Analysis, 2022
Figure 252: Global Vs GCC Countries Growth Comparison
Figure 253: GCC Countries Market Share Analysis (%) by Product, 2022 & 2033
Figure 254: GCC Countries Market Share Analysis (%) by Technique, 2022 & 2033
Figure 255: GCC Countries Market Share Analysis (%) by Sample, 2022 & 2033
Figure 256: GCC Countries Market Share Analysis (%) by End User, 2022 & 2033
Figure 257: Türkiye Market Value Proportion Analysis, 2022
Figure 258: Global Vs. Türkiye Growth Comparison
Figure 259: Türkiye Market Share Analysis (%) by Product, 2022 & 2033
Figure 260: Türkiye Market Share Analysis (%) by Technique, 2022 & 2033
Figure 261: Türkiye Market Share Analysis (%) by Sample, 2022 & 2033
Figure 262: Türkiye Market Share Analysis (%) by End User, 2022 & 2033
Figure 263: Israel Market Value Proportion Analysis, 2022
Figure 264: Global Vs. Israel Growth Comparison
Figure 265: Israel Market Share Analysis (%) by Product, 2022 & 2033
Figure 266: Israel Market Share Analysis (%) by Technique, 2022 & 2033
Figure 267: Israel Market Share Analysis (%) by Sample, 2022 & 2033
Figure 268: Israel Market Share Analysis (%) by End User, 2022 & 2033
Figure 269: South Africa Market Value Proportion Analysis, 2022
Figure 270: Global Vs. South Africa Growth Comparison
Figure 271: South Africa Market Share Analysis (%) by Product, 2022 & 2033
Figure 272: South Africa Market Share Analysis (%) by Technique, 2022 & 2033
Figure 273: South Africa Market Share Analysis (%) by Sample, 2022 & 2033
Figure 274: South Africa Market Share Analysis (%) by End User, 2022 & 2033
Figure 275: North Africa Market Value Proportion Analysis, 2022
Figure 276: Global Vs North Africa Growth Comparison
Figure 277: North Africa Market Share Analysis (%) by Product, 2022 & 2033
Figure 278: North Africa Market Share Analysis (%) by Technique, 2022 & 2033
Figure 279: North Africa Market Share Analysis (%) by Sample, 2022 & 2033
Figure 280: North Africa Market Share Analysis (%) by End User, 2022 & 2033
